Sanofi Finalizes Zentiva Sale With Focus Back On Turnaround

A share purchase agreement for the sale of Zentiva has been signed with private equity group Advent, so Sanofi can concentrate on making the most of its new acquisitions.

Potter
Sanofi reshaping its business

More from Deals

More from Business